XML 103 R41.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2020
Segment Reporting [Abstract]  
Summary of segment performance
The following table reflects adjustments to previously reported costs in our Unallocated segment, that are now allocated to our CAG, Water, LPD and Other segments for the three months ended March 31, 2019:
(in thousands)
 
 
 
 
 
 
 
 
 
 
 
 
CAG
 
Water
 
LPD
 
Other
 
Unallocated
 
 
 
 
 
 
 
 
 
 
 
Cost of sales
 
$
(182
)
 
$
(8
)
 
$
(10
)
 
$
(4
)
 
$
204

Gross profit
 
182


8


10


4


(204
)
 
 
 
 
 
 
 
 
 
 
 
Operating Expenses:
 
 
 
 
 
 
 
 
 
 
Sales and marketing
 
$
129

 
$
6

 
$
7

 
$

 
$
(142
)
General and administrative
 
(202
)
 
(40
)
 
(47
)
 
215

 
74

Research and development
 
3,558

 
9

 
11

 

 
(3,578
)
Total operating expenses
 
3,485


(25
)

(29
)

215


(3,646
)
Income from operations
 
$
(3,303
)

$
33


$
39


$
(211
)

$
3,442



The following is a summary of segment performance:

(in thousands)
 
For the Three Months Ended March 31,

 
CAG
 
Water
 
LPD
 
Other
 
Consolidated Total
2020
 
 

 
 

 
 

 
 

 
 

Revenue
 
$
551,996

 
$
34,149

 
$
34,154

 
$
6,037

 
$
626,336


 
 
 
 
 
 
 
 
 
 
Income from operations
 
$
118,659

 
$
15,882

 
$
9,663

 
$
121

 
$
144,325

Interest expense, net
 
 
 
 
 
 
 
 
 
(7,552
)
Income before provision for income taxes
 
 
 
 
 
 
 
 
 
136,773

Provision for income taxes
 
 
 
 
 
 
 
 
 
24,917

Net income
 
 
 
 
 
 
 
 
 
111,856

Less: Net income attributable to noncontrolling interest
 
 
 
 
 
 
 
 
 
29

Net income attributable to IDEXX Laboratories, Inc. stockholders
 
 
 
 
 
 
 
 
 
$
111,827


 
 
 
 
 
 
 
 
 
 
2019
 
 
 
 
 
 
 
 
 
 
Revenue
 
$
508,918

 
$
30,310

 
$
31,506

 
$
5,322

 
$
576,056


 
 
 
 
 
 
 
 
 
 
Income from operations
 
$
111,719

 
$
13,815

 
$
6,289

 
$
1,315

 
$
133,138

Interest expense, net
 
 
 
 
 
 
 
 
 
(8,346
)
Income before provision for income taxes
 
 
 
 
 
 
 
 
 
124,792

Provision for income taxes
 
 
 
 
 
 
 
 
 
22,083

Net income
 
 
 
 
 
 
 
 
 
102,709

Less: Net income attributable to noncontrolling interest
 
 
 
 
 
 
 
 
 
28

Net income attributable to IDEXX Laboratories, Inc. stockholders
 
 
 
 
 
 
 
 
 
$
102,681